Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fmr Llc Insider Profile
25 Followers
Fmr Llc, See Remark 1 at Blueprint Medicines, holds 4.54M shares in Sana Biotechnology (Ticker: SANA), holds 1.12M shares in Bicara Therapeutics Inc. (Ticker: BCAX), holds 4.01M shares in Beam Therapeutics (Ticker: BEAM). Most recently, Fmr Llc Sold ― shares of Sana Biotechnology on Jan 10, 2025 for an estimated value of 1.89M.
Profitable Transactions
33 out of 57 Profitable Transactions
Average Return
+8.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Fmr Llc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Fmr Llc
Fmr Llc's Trading History
Blueprint Medicines
Nov 30, 2015
See Remark 1
Informative Sell
6.17M
$29.15M
Viewray
Aug 10, 2018
See Remark 1
Informative Sell
2.00M
$7.28K
Aclaris Therapeutics
Aug 18, 2017
See Remark 1, Ten Percent Owner
Informative Buy
―
$6.83M
Kineta
Mar 15, 2017
See Remark 1, Ten Percent Owner
Informative Sell
323.50K
$197.82K
Dimension Therapeutics Inc
Nov 09, 2017
―
Uninformative Sell
29.36M
$0.00
Denali Therapeutics
Dec 14, 2017
See Remark 1
Uninformative Buy
―
$107.24M
VYNE Therapeutics
Jan 31, 2018
See Remark 1
Uninformative Buy
―
$3.02M
Cogent Biosciences
Apr 05, 2018
See Remark 1
Uninformative Buy
―
$19.37M
Surface Oncology
Apr 25, 2018
―
Uninformative Buy
―
$2.02M
Precision BioSciences
Apr 03, 2019
See Remark 1
Uninformative Buy
―
$18.54M
Orchard Therapeutics
Jan 06, 2020
―
Informative Buy
117.38K
$204.48M
Beam Therapeutics
Feb 15, 2024
See Remark 1
Informative Sell
27.55M
$93.93M
Flywire
Jun 02, 2021
See Remark 1
Uninformative Buy
―
$295.02M
Verve Therapeutics
Jul 14, 2022
See Remark 1
Informative Sell
3.39M
$3.50M
Caribou Biosciences
Jul 29, 2021
See Remark 1
Uninformative Buy
―
$5.08M
Rallybio
Aug 04, 2021
See Remark 1
Uninformative Buy
―
$1.48M
Xilio Therapeutics
Oct 28, 2021
See Remark 1
Uninformative Buy
―
$2.20M
Toast Inc
―
See Remark 1
―
―
Prime Medicine, Inc.
Oct 26, 2022
See Remark 1
Uninformative Buy
―
$24.46M
Turnstone Biologics Corp.
Jul 27, 2023
See Remark 1
Uninformative Buy
―
$500.09K
Neumora Therapeutics, Inc.
Sep 21, 2023
See Remark 1
Uninformative Buy
―
$15.45M
Structure Therapeutics, Inc. Sponsored ADR
―
See Remark 1
―
$15.58M
Bicara Therapeutics Inc.
Sep 18, 2024
See Remark 1
Uninformative Buy
―
$13.51M
Sana Biotechnology
Jan 10, 2025
See Remark 1, Ten Percent Owner
Informative Sell
1.89M
$14.35M
Tetraphase
Mar 09, 2015
―
Uninformative Sell
―
$0.00
Ultragenyx Pharmaceutical
Aug 05, 2014
See Remark 1.
Uninformative Sell
―
$58.32M
Xoom Corp
Aug 30, 2013
―
Uninformative Sell
14.66M
―
Generac Holdings
Jul 03, 2014
See Remark 1
Informative Buy
1.28M
$241.69M
Ironwood Pharma
Apr 02, 2013
Edward C. Johnson 3d
Informative Sell
2.91M
$3.07M
Insmed
Jul 23, 2013
Edward C. Johnson 3d, Ten Percent Owner
Informative Sell
1.91M
$161.04K
Asiainfo-Linkage
May 14, 2009
―
Informative Buy
―
―
GT Advanced Technologies Inc.
May 29, 2014
―
Informative Sell
7.42M
―
Exa Corp
Oct 11, 2016
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Fmr Llc's performance on stock
You May Also Like
Fmr Llc insider profile FAQ
What is the percentage of profitable transactions made by Fmr Llc?
The percentage of profitable transactions made by Fmr Llc is 58%.
What is the average return per transaction made by Fmr Llc?
The average return per transaction made by Fmr Llc is 8.40%.
What stocks does Fmr Llc hold?
Fmr Llc holds: BPMC, VRAYQ, ACRS, KANT, DMTX, DNLI, VYNE, COGT, SURF, DTIL, ORTX, BEAM, FLYW, VERV, CRBU, RLYB, XLO, TOST, PRME, TSBX, NMRA, GPCR, BCAX, SANA, TTPH, RARE, XOOM, GNRC, IRWD, INSM, ~ASIA, GTATQ, EXA stocks.
What was Fmr Llc’s latest transaction?
Fmr Llc latest transaction was an Informative Sell of $1.89M.
What was Fmr Llc's most profitable transaction?
Fmr Llc’s most profitable transaction was an Informative Buy of VRAYQ stock on March 30, 2016. The return on the trade was 104.30%.
What is Fmr Llc's role in Blueprint Medicines?
Fmr Llc's role in Blueprint Medicines is See Remark 1.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.